Technical Product Leader @ (May 2014 - November 2023)
Global CMC Project Leader @ (July 2013 - May 2014)
Principal @ MG Consulting (May 2010 - July 2013)
Vice President, CMC Technologies @ (October 2005 - January 2010)
Associate Research Fellow, Chemical Research and Development @ (June 1999 - October 2005)
Research Scientist, Chemical Process Research and Development @ (February 1995 - April 1999)
Mark Guzman Education
University of Pennsylvania
Ph D (Organic Chemistry)
1989-1995
University of Illinois Urbana-Champaign
B.S. (Chemistry)
1985-1988
Mark Guzman Skills
Biopharmaceuticals
Biotechnology
CMC
CMC development
CRO
CRO Management
Chromatography
Clinical Trials
Drug Development
FDA
GMP
HPLC
Organic Chemistry
Pharmaceutical Industry
Pharmaceuticals
Process Simulation
Protein Chemistry
Regulatory Requirements
Technology Transfer
V&V
Validation
cGMP
Writing
Cardiovascular Disease
New York City
Substance
Chemical
Chemistry
Net
Infectious Diseases
Cost
Oligonucleotides
Macular Degeneration
Wood
Clinical Research
Derivatives
Commercialization
Advancement
Supply Chain Management
Minerva
Regulatory Affairs
Structure
Coupling
Franchising
Executive Positions
Introducing
Lung Cancer
Symposium
Work Ethic
Las Vegas
Campbell
Strand
Deepwater
FMCG
APIs
NDA
Clinical Development
Int
Treatment
Disclosures
Cancer
Acid
C Level
Regulatory Agencies
Management
Design
Outsourcing
Phase 1
Route
Hla
Therapeutic Areas
Patents
Toxicology
HIV
Impd
Initiation
Pfizer
Publications
Conjugation
Collaborative
Pennsylvania
Execution
Written Correspondence
Face To Face
Multifunctional
Drug Product
Co Development
Philadelphia
Interdisciplinary Teaching
Reaction
Portfolio Management
Process Validation
Telecommunications
Cell
Professors
In Licensing
Strategy
Alkylation
Stability Studies
Crystal
Agreement
Pharmaceutical Sciences
Cooperative
Chiral
Intermediates
Denver
SoC
Editing
Hepatitis B
Regulatory Interactions
Progression
Regulatory Submissions
Peptidomimetics
Flu
Product Development
American
Research
Quality Control
Chemists
Stakeholders
Chemical Research
Commercial Real Estate
R&D
Board of Directors
Analysis
Mindset
Abstracts
R
Comments
C
Enzymes
On Budget
Regulatory Filings
Applications
Maa
Communication
Home
Evidence
Active
Sheet
Strategic Planning
Scientific
Microwave
Characterization
Stage
Biopolymers
Analytical Chemistry
Critical Thinking
Social Influence
Pharmacology
Project
Governance
Molecular Modeling
Golang
Contractual Agreements
Surface
Facilities Management
Matthews
Presentations
CTA
Internal Audit
Usa
Regulations
Distribution
International
X Ray
Purchasing
Allergy
Germany
Efficient
Transparency
cGMP manufacturing
HEV
Class Ii
Logic Synthesis
Technical Leadership
Sourcing
Reviews
Hepatitis
Materials
Ping
Business Objects
San Francisco
Berkeley
Deliveries
Business Planning
Phase
Process Research
Canada
Watson
Pharmaceutics
Manufacturing
Biologics
Antigen
Antiviral
AMOS
Budgets
Formulation
Central Nervous System
Staff Development
Optimization
Due Diligence
SAP R/3
Problem Solving
Broad Experience
Meetings
Amendments
Tao
Political Campaigns
Delivery
Abstraction
Iss
EMEA
Analytical Method Validation
Evaluation
Coordinated
Selling
Mark Guzman Summary
Mark Guzman, based in Berkeley, CA, US, is currently a Executive Director, Product Strategy Leader at Gilead Sciences. Mark Guzman brings experience from previous roles at Genentech, Onyx Pharmaceuticals, MG Consulting and Dynavax Technologies. Mark Guzman holds a 1989 - 1995 Ph D in Organic Chemistry @ University of Pennsylvania. With a robust skill set that includes Biopharmaceuticals, Biotechnology, CMC, CMC development, CRO and more. Mark Guzman has 1 mobile phone numbers on RocketReach.
Looking for a different Mark Guzman?
Find contact details for 700 million professionals.